Indeed, immunogenicity of the tumor plays a crucial role in response to ICI treatments: tumors with high lymphocytes and tumor-infiltrating T-cells (TILs) in tumor microenvironment, as well as high levels of anti PDL-1 expression on the tumor, are predictive for response to ICI [3,22]. Here, CD274 is linked to neoplasm.